Annual Net Income
-$141.43 M
-$29.10 M-25.91%
31 December 2023
Summary:
Celldex Therapeutics annual net profit is currently -$141.43 million, with the most recent change of -$29.10 million (-25.91%) on 31 December 2023. During the last 3 years, it has fallen by -$81.65 million (-136.58%). CLDX annual net income is now -17578.63% below its all-time high of -$800.00 thousand, reached on 30 April 1987.CLDX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$42.12 M
-$6.28 M-17.52%
01 September 2024
Summary:
Celldex Therapeutics quarterly net profit is currently -$42.12 million, with the most recent change of -$6.28 million (-17.52%) on 01 September 2024. Over the past year, it has dropped by -$3.86 million (-10.09%). CLDX quarterly net income is now -285.87% below its all-time high of $22.66 million, reached on 31 December 2010.CLDX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$154.08 M
-$3.86 M-2.57%
01 September 2024
Summary:
Celldex Therapeutics TTM net profit is currently -$154.08 million, with the most recent change of -$3.86 million (-2.57%) on 01 September 2024. Over the past year, it has dropped by -$29.47 million (-23.65%). CLDX TTM net income is now -51259.00% below its all-time high of -$300.00 thousand, reached on 01 July 1985.CLDX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.9% | -10.1% | -23.6% |
| 3 y3 years | -136.6% | -106.0% | -113.2% |
| 5 y5 years | +6.5% | -269.1% | -209.2% |
CLDX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -136.6% | at low | -109.1% | +2.7% | -118.5% | at low |
| 5 y | 5 years | -178.0% | +6.5% | -303.2% | +2.7% | -238.5% | at low |
| alltime | all time | <-9999.0% | +6.5% | -285.9% | +64.3% | <-9999.0% | +12.9% |
Celldex Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$42.12 M(+17.5%) | -$154.08 M(+2.6%) |
| June 2024 | - | -$35.84 M(+9.2%) | -$150.22 M(+3.7%) |
| Mar 2024 | - | -$32.81 M(-24.2%) | -$144.88 M(+2.4%) |
| Dec 2023 | -$141.43 M(+25.9%) | -$43.31 M(+13.2%) | -$141.43 M(+13.5%) |
| Sept 2023 | - | -$38.26 M(+25.4%) | -$124.61 M(+10.1%) |
| June 2023 | - | -$30.50 M(+3.9%) | -$113.13 M(-4.6%) |
| Mar 2023 | - | -$29.36 M(+10.9%) | -$118.64 M(+5.6%) |
| Dec 2022 | -$112.33 M(+59.3%) | -$26.49 M(-1.1%) | -$112.33 M(+6.0%) |
| Sept 2022 | - | -$26.78 M(-25.6%) | -$105.99 M(+6.4%) |
| June 2022 | - | -$36.00 M(+56.2%) | -$99.65 M(+29.4%) |
| Mar 2022 | - | -$23.05 M(+14.4%) | -$77.02 M(+9.2%) |
| Dec 2021 | -$70.51 M(+18.0%) | -$20.15 M(-1.5%) | -$70.51 M(-2.4%) |
| Sept 2021 | - | -$20.45 M(+52.9%) | -$72.26 M(+9.4%) |
| June 2021 | - | -$13.37 M(-19.1%) | -$66.03 M(+3.7%) |
| Mar 2021 | - | -$16.54 M(-24.5%) | -$63.69 M(+6.5%) |
| Dec 2020 | -$59.78 M(+17.5%) | -$21.90 M(+54.0%) | -$59.78 M(+23.7%) |
| Sept 2020 | - | -$14.22 M(+28.9%) | -$48.33 M(+6.2%) |
| June 2020 | - | -$11.03 M(-12.6%) | -$45.52 M(-1.6%) |
| Mar 2020 | - | -$12.63 M(+20.8%) | -$46.26 M(-9.1%) |
| Dec 2019 | -$50.88 M(-66.3%) | -$10.45 M(-8.5%) | -$50.88 M(+2.1%) |
| Sept 2019 | - | -$11.41 M(-3.1%) | -$49.83 M(+9.1%) |
| June 2019 | - | -$11.78 M(-31.7%) | -$45.66 M(-9.2%) |
| Mar 2019 | - | -$17.24 M(+83.3%) | -$50.29 M(-66.7%) |
| Dec 2018 | -$151.18 M(+62.5%) | -$9.40 M(+29.8%) | -$151.19 M(+3.8%) |
| Sept 2018 | - | -$7.24 M(-55.9%) | -$145.62 M(-11.6%) |
| June 2018 | - | -$16.41 M(-86.1%) | -$164.74 M(-6.9%) |
| Mar 2018 | - | -$118.13 M(+2975.6%) | -$176.90 M(+90.2%) |
| Dec 2017 | -$93.03 M(-27.6%) | -$3.84 M(-85.4%) | -$93.03 M(-23.4%) |
| Sept 2017 | - | -$26.36 M(-7.7%) | -$121.50 M(-2.6%) |
| June 2017 | - | -$28.57 M(-16.6%) | -$124.73 M(-2.6%) |
| Mar 2017 | - | -$34.26 M(+6.0%) | -$128.12 M(-0.3%) |
| Dec 2016 | -$128.53 M(+1.0%) | -$32.31 M(+9.2%) | -$128.53 M(-0.3%) |
| Sept 2016 | - | -$29.60 M(-7.4%) | -$128.91 M(-1.8%) |
| June 2016 | - | -$31.95 M(-7.8%) | -$131.29 M(-0.3%) |
| Mar 2016 | - | -$34.67 M(+6.1%) | -$131.70 M(+3.5%) |
| Dec 2015 | -$127.20 M(+7.7%) | -$32.68 M(+2.2%) | -$127.20 M(+0.7%) |
| Sept 2015 | - | -$31.98 M(-1.2%) | -$126.33 M(+3.2%) |
| June 2015 | - | -$32.36 M(+7.2%) | -$122.44 M(+3.5%) |
| Mar 2015 | - | -$30.17 M(-5.2%) | -$118.35 M(+0.2%) |
| Dec 2014 | -$118.08 M(+44.8%) | -$31.82 M(+13.3%) | -$118.08 M(+9.0%) |
| Sept 2014 | - | -$28.08 M(-0.7%) | -$108.32 M(+4.8%) |
| June 2014 | - | -$28.27 M(-5.4%) | -$103.38 M(+9.8%) |
| Mar 2014 | - | -$29.90 M(+35.5%) | -$94.12 M(+15.4%) |
| Dec 2013 | -$81.55 M(+37.9%) | -$22.06 M(-4.7%) | -$81.55 M(+6.9%) |
| Sept 2013 | - | -$23.14 M(+21.7%) | -$76.30 M(+11.9%) |
| June 2013 | - | -$19.02 M(+9.7%) | -$68.18 M(+8.3%) |
| Mar 2013 | - | -$17.33 M(+3.1%) | -$62.94 M(+6.5%) |
| Dec 2012 | -$59.12 M(+32.0%) | -$16.81 M(+11.8%) | -$59.12 M(+7.4%) |
| Sept 2012 | - | -$15.03 M(+9.1%) | -$55.05 M(+6.3%) |
| June 2012 | - | -$13.77 M(+1.9%) | -$51.79 M(+7.3%) |
| Mar 2012 | - | -$13.52 M(+6.2%) | -$48.26 M(+7.7%) |
| Dec 2011 | -$44.80 M(+1668.6%) | -$12.73 M(+8.2%) | -$44.80 M(+376.3%) |
| Sept 2011 | - | -$11.77 M(+15.0%) | -$9.41 M(+39.9%) |
| June 2011 | - | -$10.24 M(+1.8%) | -$6.72 M(+11.8%) |
| Mar 2011 | - | -$10.06 M(-144.4%) | -$6.01 M(+137.3%) |
| Dec 2010 | -$2.53 M(-93.1%) | $22.66 M(-349.4%) | -$2.53 M(-93.4%) |
| Sept 2010 | - | -$9.09 M(-4.6%) | -$38.14 M(+5.3%) |
| June 2010 | - | -$9.53 M(+44.7%) | -$36.22 M(+2.3%) |
| Mar 2010 | - | -$6.58 M(-49.1%) | -$35.40 M(-3.1%) |
| Dec 2009 | -$36.52 M(-23.1%) | -$12.94 M(+80.4%) | -$36.52 M(+17.7%) |
| Sept 2009 | - | -$7.17 M(-17.6%) | -$31.04 M(-1.5%) |
| June 2009 | - | -$8.71 M(+13.0%) | -$31.52 M(-4.7%) |
| Mar 2009 | - | -$7.70 M(+3.3%) | -$33.07 M(-30.4%) |
| Dec 2008 | -$47.50 M(+215.1%) | -$7.45 M(-2.6%) | -$47.50 M(+7.3%) |
| Sept 2008 | - | -$7.66 M(-25.4%) | -$44.28 M(+8.8%) |
| June 2008 | - | -$10.26 M(-53.6%) | -$40.68 M(+22.6%) |
| Mar 2008 | - | -$22.13 M(+423.4%) | -$33.17 M(+120.1%) |
| Dec 2007 | -$15.07 M(-15.5%) | -$4.23 M(+4.2%) | -$15.07 M(+3.8%) |
| Sept 2007 | - | -$4.06 M(+47.3%) | -$14.52 M(-9.2%) |
| June 2007 | - | -$2.76 M(-31.7%) | -$15.98 M(-15.4%) |
| Mar 2007 | - | -$4.03 M(+9.8%) | -$18.90 M(+6.0%) |
| Dec 2006 | -$17.84 M(-1.4%) | -$3.67 M(-33.5%) | -$17.84 M(-1.7%) |
| Sept 2006 | - | -$5.52 M(-2.6%) | -$18.14 M(+5.9%) |
| June 2006 | - | -$5.67 M(+90.9%) | -$17.14 M(+5.8%) |
| Mar 2006 | - | -$2.97 M(-25.3%) | -$16.20 M(-10.5%) |
| Dec 2005 | -$18.10 M(+37.1%) | -$3.98 M(-11.8%) | -$18.10 M(+1.6%) |
| Sept 2005 | - | -$4.51 M(-4.6%) | -$17.82 M(+4.8%) |
| June 2005 | - | -$4.73 M(-2.8%) | -$17.00 M(+5.2%) |
| Mar 2005 | - | -$4.87 M(+31.6%) | -$16.16 M(+22.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2004 | -$13.20 M(+4.2%) | -$3.70 M(+0.0%) | -$13.20 M(-2.3%) |
| Sept 2004 | - | -$3.70 M(-5.2%) | -$13.51 M(+13.3%) |
| June 2004 | - | -$3.90 M(+104.2%) | -$11.93 M(+6.4%) |
| Mar 2004 | - | -$1.91 M(-52.4%) | -$11.22 M(-11.5%) |
| Dec 2003 | -$12.67 M(-8.4%) | -$4.01 M(+89.5%) | -$12.67 M(+4.4%) |
| Sept 2003 | - | -$2.12 M(-33.5%) | -$12.14 M(+17.9%) |
| June 2003 | - | -$3.18 M(-5.3%) | -$10.30 M(-16.1%) |
| Mar 2003 | - | -$3.36 M(-3.2%) | -$12.28 M(-11.2%) |
| Dec 2002 | -$13.83 M(-39.2%) | -$3.48 M(+1158.2%) | -$13.83 M(-19.6%) |
| Sept 2002 | - | -$276.20 K(-94.7%) | -$17.21 M(-25.7%) |
| June 2002 | - | -$5.16 M(+5.1%) | -$23.16 M(-2.1%) |
| Mar 2002 | - | -$4.91 M(-28.3%) | -$23.65 M(+4.0%) |
| Dec 2001 | -$22.75 M(+3.5%) | -$6.86 M(+10.1%) | -$22.74 M(-22.6%) |
| Sept 2001 | - | -$6.22 M(+10.0%) | -$29.38 M(+9.7%) |
| June 2001 | - | -$5.66 M(+41.4%) | -$26.79 M(+12.3%) |
| Mar 2001 | - | -$4.00 M(-70.3%) | -$23.86 M(+8.6%) |
| Dec 2000 | -$21.98 M(+94.3%) | -$13.49 M(+271.4%) | -$21.98 M(+81.8%) |
| Sept 2000 | - | -$3.63 M(+33.4%) | -$12.09 M(+9.3%) |
| June 2000 | - | -$2.72 M(+28.3%) | -$11.06 M(+3.0%) |
| Mar 2000 | - | -$2.12 M(-41.2%) | -$10.73 M(-5.1%) |
| Dec 1999 | -$11.31 M(-78.2%) | -$3.61 M(+38.8%) | -$11.31 M(+13.1%) |
| Sept 1999 | - | -$2.60 M(+8.3%) | -$10.00 M(-81.5%) |
| June 1999 | - | -$2.40 M(-11.1%) | -$54.20 M(+2.1%) |
| Mar 1999 | - | -$2.70 M(+17.4%) | -$53.10 M(+2.5%) |
| Dec 1998 | -$51.80 M(+295.4%) | -$2.30 M(-95.1%) | -$51.80 M(+1.6%) |
| Sept 1998 | - | -$46.80 M(+3500.0%) | -$51.00 M(+318.0%) |
| June 1998 | - | -$1.30 M(-7.1%) | -$12.20 M(-3.2%) |
| Mar 1998 | - | -$1.40 M(-6.7%) | -$12.60 M(-3.8%) |
| Dec 1997 | -$13.10 M(+21.3%) | -$1.50 M(-81.3%) | -$13.10 M(-6.4%) |
| Sept 1997 | - | -$8.00 M(+370.6%) | -$14.00 M(+68.7%) |
| June 1997 | - | -$1.70 M(-10.5%) | -$8.30 M(-23.9%) |
| Mar 1997 | - | -$1.90 M(-20.8%) | -$10.90 M(0.0%) |
| Dec 1996 | -$10.80 M(+30.1%) | -$2.40 M(+4.3%) | -$10.90 M(+25.3%) |
| Sept 1996 | - | -$2.30 M(-46.5%) | -$8.70 M(-8.4%) |
| June 1996 | - | -$4.30 M(+126.3%) | -$9.50 M(+21.8%) |
| Mar 1996 | - | -$1.90 M(+850.0%) | -$7.80 M(-6.0%) |
| Dec 1995 | -$8.30 M(-28.4%) | -$200.00 K(-93.5%) | -$8.30 M(-33.6%) |
| Sept 1995 | - | -$3.10 M(+19.2%) | -$12.50 M(+0.8%) |
| June 1995 | - | -$2.60 M(+8.3%) | -$12.40 M(+2.5%) |
| Mar 1995 | - | -$2.40 M(-45.5%) | -$12.10 M(+4.3%) |
| Dec 1994 | -$11.60 M(+48.7%) | -$4.40 M(+46.7%) | -$11.60 M(+23.4%) |
| Sept 1994 | - | -$3.00 M(+30.4%) | -$9.40 M(+6.8%) |
| June 1994 | - | -$2.30 M(+21.1%) | -$8.80 M(+10.0%) |
| Mar 1994 | - | -$1.90 M(-13.6%) | -$8.00 M(+2.6%) |
| Dec 1993 | -$7.80 M(+116.7%) | -$2.20 M(-8.3%) | -$7.80 M(+39.3%) |
| Sept 1993 | - | -$2.40 M(+60.0%) | -$5.60 M(+30.2%) |
| June 1993 | - | -$1.50 M(-11.8%) | -$4.30 M(+7.5%) |
| Mar 1993 | - | -$1.70 M(+54.5%) | -$4.00 M(-2.4%) |
| Dec 1992 | -$3.60 M(-21.7%) | - | - |
| Oct 1992 | - | -$1.10 M(-8.3%) | -$4.10 M(-8.9%) |
| July 1992 | - | -$1.20 M(-14.3%) | -$4.50 M(-2.2%) |
| Apr 1992 | - | -$1.40 M(+250.0%) | -$4.60 M(+12.2%) |
| Apr 1992 | -$4.60 M(+35.3%) | - | - |
| Jan 1992 | - | -$400.00 K(-73.3%) | -$4.10 M(-8.9%) |
| Oct 1991 | - | -$1.50 M(+15.4%) | -$4.50 M(+21.6%) |
| July 1991 | - | -$1.30 M(+44.4%) | -$3.70 M(+8.8%) |
| Apr 1991 | -$3.40 M(+240.0%) | -$900.00 K(+12.5%) | -$3.40 M(+54.5%) |
| Jan 1991 | - | -$800.00 K(+14.3%) | -$2.20 M(+57.1%) |
| Oct 1990 | - | -$700.00 K(-30.0%) | -$1.40 M(0.0%) |
| July 1990 | - | -$1.00 M(-433.3%) | -$1.40 M(+40.0%) |
| Apr 1990 | -$1.00 M(-9.1%) | $300.00 K(-142.9%) | -$1.00 M(-41.2%) |
| Oct 1989 | - | -$700.00 K(+16.7%) | -$1.70 M(+21.4%) |
| July 1989 | - | -$600.00 K(-700.0%) | -$1.40 M(+27.3%) |
| Apr 1989 | -$1.10 M(-8.3%) | $100.00 K(-120.0%) | -$1.10 M(-26.7%) |
| Jan 1989 | - | -$500.00 K(+25.0%) | -$1.50 M(+15.4%) |
| Oct 1988 | - | -$400.00 K(+33.3%) | -$1.30 M(+18.2%) |
| July 1988 | - | -$300.00 K(0.0%) | -$1.10 M(-8.3%) |
| Apr 1988 | -$1.20 M(+50.0%) | -$300.00 K(0.0%) | -$1.20 M(0.0%) |
| Jan 1988 | - | -$300.00 K(+50.0%) | -$1.20 M(+20.0%) |
| Oct 1987 | - | -$200.00 K(-50.0%) | -$1.00 M(+11.1%) |
| July 1987 | - | -$400.00 K(+33.3%) | -$900.00 K(+12.5%) |
| Apr 1987 | -$800.00 K(-52.9%) | -$300.00 K(+200.0%) | -$800.00 K(-76.5%) |
| Jan 1987 | - | -$100.00 K(0.0%) | -$3.40 M(-12.8%) |
| Oct 1986 | - | -$100.00 K(-66.7%) | -$3.90 M(-7.1%) |
| July 1986 | - | -$300.00 K(-89.7%) | -$4.20 M(0.0%) |
| Apr 1986 | -$1.70 M | -$2.90 M(+383.3%) | -$4.20 M(+223.1%) |
| Jan 1986 | - | -$600.00 K(+50.0%) | -$1.30 M(+85.7%) |
| Oct 1985 | - | -$400.00 K(+33.3%) | -$700.00 K(+133.3%) |
| July 1985 | - | -$300.00 K | -$300.00 K |
FAQ
- What is Celldex Therapeutics annual net profit?
- What is the all time high annual net income for Celldex Therapeutics?
- What is Celldex Therapeutics annual net income year-on-year change?
- What is Celldex Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly net income year-on-year change?
- What is Celldex Therapeutics TTM net profit?
- What is the all time high TTM net income for Celldex Therapeutics?
- What is Celldex Therapeutics TTM net income year-on-year change?
What is Celldex Therapeutics annual net profit?
The current annual net income of CLDX is -$141.43 M
What is the all time high annual net income for Celldex Therapeutics?
Celldex Therapeutics all-time high annual net profit is -$800.00 K
What is Celldex Therapeutics annual net income year-on-year change?
Over the past year, CLDX annual net profit has changed by -$29.10 M (-25.91%)
What is Celldex Therapeutics quarterly net profit?
The current quarterly net income of CLDX is -$42.12 M
What is the all time high quarterly net income for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly net profit is $22.66 M
What is Celldex Therapeutics quarterly net income year-on-year change?
Over the past year, CLDX quarterly net profit has changed by -$3.86 M (-10.09%)
What is Celldex Therapeutics TTM net profit?
The current TTM net income of CLDX is -$154.08 M
What is the all time high TTM net income for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM net profit is -$300.00 K
What is Celldex Therapeutics TTM net income year-on-year change?
Over the past year, CLDX TTM net profit has changed by -$29.47 M (-23.65%)